Other
VOC analysis
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Terminated(1)
Other(4)
Detailed Status
unknown4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
terminated120%
unknown480%
Recent Activity
0 active trials
Showing 5 of 5
unknownnot_applicable
Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)
NCT05029349
terminatednot_applicable
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response
NCT03988192
unknownnot_applicable
Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)
NCT04816695
unknownnot_applicable
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03988790
unknownnot_applicable
Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection
NCT03803137
Clinical Trials (5)
Showing 5 of 5 trials
NCT05029349Not Applicable
Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)
NCT03988192Not Applicable
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response
NCT04816695Not Applicable
Volatolom Variation in Severe COPD During Hospitalization for Exacerbation and After Hospitalization (VOC-BPCO-Exa)
NCT03988790Not Applicable
Evaluation of the Response to Monoclonal Antibody Therapy in Severe Asthma: Research of Predictive Biomarkers in Exhaled Air
NCT03803137Not Applicable
Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5